Compare SSTK & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSTK | SLBT |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.9M | 644.9M |
| IPO Year | 2012 | 2025 |
| Metric | SSTK | SLBT |
|---|---|---|
| Price | $2.20 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 901.5K | 46.5K |
| Earning Date | 11-05-2026 | 10-26-2026 |
| Dividend Yield | ★ 44.49% | N/A |
| EPS Growth | ★ 23.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $0.57 |
| 52 Week High | $21.68 | $6.25 |
| Indicator | SSTK | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 24.82 | 22.09 |
| Support Level | N/A | N/A |
| Resistance Level | $4.67 | $1.75 |
| Average True Range (ATR) | 0.33 | 0.13 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 1.24 | 4.94 |
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.